Nanobots for bladder cancer treatment, promising high efficacy and targeted delivery

A study in Nature Nanotechnology reveals the potential of urease-powered nanobots to enhance bladder cancer treatment, showing a 90% tumor reduction in a mouse model using radioiodine-loaded nanobots for targeted therapy.

Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise

Atlas Venture, one of biotech’s go-to VC firms, is eyeing a $450 million 14th fund, partner Bruce Booth said in its annual review presentation. …

November 19, 2024

Climate change to boost temperature-related deaths in Europe

A first pan-European assessment reveals that, even if current climate policies succeed in limiting the global temperature rise to 3°C, temperature-driven mortality may increase.

August 22, 2024

Gerresheimer builds new production capacities for glass syringes at Skopje site – Biotech Investments

EQS-News: Gerresheimer AG / Key word(s): Expansion Gerresheimer builds new production capacities for glass syringes at Skopje site 02.12.2024 / 13:30 CET/CEST The issuer is

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.